溶酶体保护蛋白/组织蛋白酶A基因敲除小鼠听力和耳形态学初步研究

Morphological and Functional Alterations of Ear in Lysosomal Protective Protein/Cathepsin A Gene Knock Out Mouse

郭运凯;谢鼎华;杨新明;

1:中南大学湘雅二医院耳鼻咽喉科和听力研究所

2:中南大学湘雅二医院耳鼻咽喉科和听力研究所

3:中南大学湘雅二医院耳鼻咽喉科和听力研究所 长沙410011

4:长沙410011

摘要
目的研究溶酶体保护蛋白/组织蛋白酶A(protective protein/cathepsin A,PPCA)基因敲除小鼠听功能和耳形态学改变,探讨半乳糖唾液酸沉积症听力损害的病理生理机制。方法应用听性脑干反应(ABR)测试和颞骨连续切片,观察1月和2月龄的PPCA基因敲除纯合子(PPCA-/-)小鼠ABR反应阈和光镜下外耳、中耳及内耳形态改变,并以野生型(PPCA+/+)小鼠作对照。结果1月龄PPCA-/-小鼠ABR反应阈和耳形态无明显改变;2月龄时,短声和短音8、163、2 kHz反应阈较PPCA+/+提高4045 dB SPL,中耳黏膜增厚、听骨细胞囊泡化、变形和关节腔融合,血管纹增厚、螺旋神经节细胞、螺旋缘纤维细胞、前庭膜、基底膜及沿前庭阶外淋巴隙的间皮细胞囊泡化,但Corti器毛细胞及支持细胞正常。结论溶酶体保护蛋白/组织蛋白酶A缺乏可导致听力损害、中耳及耳蜗形态改变、中耳炎、听骨改变以及耳蜗螺旋神经节、血管纹、螺旋缘、前庭膜和基底膜等细胞的溶酶体储积,可能分别是传导性聋和感觉神经性聋的形成机制。
关键词
溶酶体;保护蛋白/组织蛋白酶A;基因敲除;半乳糖唾液酸沉积症;溶酶体储积疾病;小鼠
基金项目(Foundation):
作者
郭运凯;谢鼎华;杨新明;
参考文献

1 d’Azzo A,Andria G,Strisciuglio P,et al.Galactosialidosis.In:Scriver CR,Beaudet AL,Sly WS and Vallee D(Eds),Metabolic andMolecular Bases of Inherited Disease[M].New York:Mc Graw-Hill,1995.2 835~2 837.

2 Rottier RJ,Hahn CN,Mann LW,et al.Lack of PPCA expression on-ly partially coincides with lysosomal storage in galactosialidosis mice:indirect evidence for spatial requirement of the catalytic rather than theprotective function of PPCA[J].Hum Mol Genet,1998,7:1 787.

3 Zhou XY,Morreau H,Rottier R,et al.Mouse model for the lysosomaldisorder galactosialidosis and correction of the phenotype with overex-pressing erythroid precursor cells[J].Genes Dev,1995,9:2 623.

4 Wu X,Gao J,Guo Y,et al.Hearing threshold elevation precedeshair-cell loss in prestin knock out mice[J].Mol Brain Res,2004,126:30.

5 Gorlin RJ.Genetic hearing loss associated with endocrine and metabolicdisorders.In:Gorlin RJ,Toriello HV,Cohen MM(Eds),Hereditaryhearing loss and its syndromes[M].New York:Oxford UniversityPress,1999.318~354.

6 Groener J,Maaswinkel-Mooy P,Smit V,et al.New mutations intwo Dutch patients with early infantile galactosialidosis[J].Mol GenetMetab,2003,78:222.

7 Zhou XY,van der Spoel A,Rottier R,et al.Molecular and biochemi-cal analysis of protective protein/cathepsin a mutations:correlationwith clinical severity in galactosialidosis[J].Hum Mol Genet,1996,5:1 977.

8 Okamura-Oho Y,Zhang S,Callahan JW.The biochemistry and cli-nical features of galactosialidosis[J].Biochim Biophys Acta,1994,1 225:244.

9 Ohlemiller KK,Hennig AK,Lett JM,et al.Inner ear pathology in themucopolysaccharidosis VII mouse[J].Hear Res,2002,169:69.

10 Coenen R,Gieselmann V,Lullmann-Rauch R.Morpholgical alte-rations in the ear of the arylsulfatase A-deficient mouse[J].ActaNeurophol,2001,101:491.